Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -655 | -504 | -253 | -553 | N/A |
| Depreciation Amortization | 48 | 26 | 13 | 54 | N/A |
| Accounts payable and accrued liabilities | 6 | 39 | 9 | -12 | N/A |
| Other Working Capital | 493 | 426 | 200 | 618 | N/A |
| Other Operating Activity | -6 | -39 | -9 | -558 | 0 |
| Operating Cash Flow | $-114 | $-52 | $-40 | $-452 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | 650 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $650 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 145 | 16 | 8 | 29 | N/A |
| Debt Issued | N/A | N/A | -46 | -195 | N/A |
| Other Financing Activity | -76 | -47 | 0 | 0 | 0 |
| Financing Cash Flow | $69 | $-30 | $-37 | $-165 | $N/A |
| Beginning Cash Position | 82 | 82 | 82 | 49 | N/A |
| End Cash Position | 37 | 0 | 4 | 82 | N/A |
| Net Cash Flow | $-45 | $-82 | $-78 | $33 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -114 | -52 | -40 | -452 | N/A |
| Free Cash Flow | -114 | -52 | -40 | -452 | 0 |